Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

HIV Infection

Free Subscription Articles published in PLoS Pathog Retrieve available abstracts of 65 articles: HTML format

Single Articles

April 2025
1. BUCHANAN LB, Shao Z, Galiwango RM, Constable S, et al
   HIV-associated penile anaerobes disrupt epithelial barrier integrity.
   PLoS Pathog. 2025;21:e1013094.
   PubMed     Abstract available
   
   
   
2. FAIZO AAA, Bellward C, Hernandez-Lopez HR, Stevenson A, et al
   The splicing factor kinase, SR protein kinase 1 (SRPK1) is essential for late events in the human papillomavirus life cycle.
   PLoS Pathog. 2025;21:e1012697.
   PubMed     Abstract available
   
   
   
3. ASHOKKUMAR M, Hafer TL, Felton A, Archin NM, et al
   A targeted CRISPR screen identifies ETS1 as a regulator of HIV-1 latency.
   PLoS Pathog. 2025;21:e1012467.
   PubMed     Abstract available
   
   
   
4. REEVES DB, Litchford M, Fish CS, Farrell-Sherman A, et al
   Intact HIV DNA decays in children with and without complete viral load suppression.
   PLoS Pathog. 2025;21:e1013003.
   PubMed     Abstract available
   
   
   
5. ZHAO W, Modak A, Ross SR
   DHX15 inhibits mouse APOBEC3 deamination.
   PLoS Pathog. 2025;21:e1013045.
   PubMed     Abstract available
   
   
   
6. SARKAR S, Kobayashi Y, Russnak T, Shen J, et al
   GS143, an inhibitor of E3 ligase beta-TrCP, reverses HIV-1 latency without activating T cells via unconventional activation of NFkappaB.
   PLoS Pathog. 2025;21:e1013018.
   PubMed     Abstract available
   
   
   
7. NOORSAEED S, AlBurtamani N, Rokan A, Fassati A, et al
   Heat shock protein 90 is a chaperone regulator of HIV-1 latency.
   PLoS Pathog. 2025;21:e1012524.
   PubMed     Abstract available
   
   
   March 2025
8. NAIR A, Davis DA, Warner A, Karim B, et al
   The elevated expression of ORF75, a KSHV lytic gene, in Kaposi sarcoma lesions is driven by a GC-rich DNA cis element in its promoter region.
   PLoS Pathog. 2025;21:e1012984.
   PubMed     Abstract available
   
   
   
9. CANDOR K, Ding L, Balchand S, Hammonds JE, et al
   The CLIC/GEEC pathway regulates particle uptake and formation of the virus-containing compartment (VCC) in HIV-1-infected macrophages.
   PLoS Pathog. 2025;21:e1012564.
   PubMed     Abstract available
   
   
   February 2025
10. IRRINKI AM, Kaur J, Randhawa B, McFadden R, et al
    Activating PKC-epsilon induces HIV expression with improved tolerability.
    PLoS Pathog. 2025;21:e1012874.
    PubMed     Abstract available
    
    
    January 2025
11. GRIFFITH GL, Machmach K, Jian N, Kim D, et al
    CD16 and CD57 expressing gamma delta T cells in acute HIV-1 infection are associated with the development of neutralization breadth.
    PLoS Pathog. 2025;21:e1012916.
    PubMed     Abstract available
    
    
    
12. SCOTT TM, Arnold LM, Powers JA, McCann DA, et al
    Cell-free assays reveal that the HIV-1 capsid protects reverse transcripts from cGAS immune sensing.
    PLoS Pathog. 2025;21:e1012206.
    PubMed     Abstract available
    
    
    
13. HUANG SW, Briganti L, Annamalai AS, Greenwood J, et al
    The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavir.
    PLoS Pathog. 2025;21:e1012862.
    PubMed     Abstract available
    
    
    
14. HUBAL A, Vendhoti A, Shaffer CN, Vos S, et al
    Inhibition of Src signaling induces autophagic killing of Toxoplasma gondii via PTEN-mediated deactivation of Akt.
    PLoS Pathog. 2025;21:e1012907.
    PubMed     Abstract available
    
    
    
15. EDWARDS CT, Karunakaran KA, Garcia E, Beutler N, et al
    Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques.
    PLoS Pathog. 2025;21:e1012456.
    PubMed     Abstract available
    
    
    
16. FOULKES C, Friedrich N, Ivan B, Stiegeler E, et al
    Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity.
    PLoS Pathog. 2025;21:e1012825.
    PubMed     Abstract available
    
    
    
17. ROHLFES N, Radhakrishnan R, Singh PK, Bedwell GJ, et al
    The nuclear localization signal of CPSF6 governs post-nuclear import steps of HIV-1 infection.
    PLoS Pathog. 2025;21:e1012354.
    PubMed     Abstract available
    
    
    
18. FARINRE O, Anaya T, King AC, Endrias K, et al
    SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques.
    PLoS Pathog. 2025;21:e1012863.
    PubMed     Abstract available
    
    
    
19. MAN S, Jansen J, Kroeze S, Geijtenbeek TBH, et al
    Transcriptomic HIV-1 reservoir profiling reveals a role for mitochondrial functionality in HIV-1 latency.
    PLoS Pathog. 2025;21:e1012822.
    PubMed     Abstract available
    
    
    
20. HU K, O'Neil TR, Baharlou H, Austin PJ, et al
    The spatial biology of HIV infection.
    PLoS Pathog. 2025;21:e1012888.
    PubMed     Abstract available
    
    
    December 2024
21. MAK NSC, Liu J, Zhang D, Taylor J, et al
    Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats.
    PLoS Pathog. 2024;20:e1012763.
    PubMed     Abstract available
    
    
    
22. GROBBEN M, Bakker M, Schriek AI, Levels LJJ, et al
    Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression.
    PLoS Pathog. 2024;20:e1012739.
    PubMed     Abstract available
    
    
    
23. RADER AG, Cloherty APM, Patel KS, Almandawi DDA, et al
    HIV-1 exploits LBPA-dependent intraepithelial trafficking for productive infection of human intestinal mucosa.
    PLoS Pathog. 2024;20:e1012714.
    PubMed     Abstract available
    
    
    
24. RICHEL E, Cordsmeier A, Bauer L, Fraedrich K, et al
    Mechanisms of sterilizing immunity provided by an HIV-1 neutralizing antibody against mucosal infection.
    PLoS Pathog. 2024;20:e1012777.
    PubMed     Abstract available
    
    
    November 2024
25. FRANZEN BOGER M, Hasselrot T, Kaldhusdal V, Miranda GHB, et al
    Sustained immune activation and impaired epithelial barrier integrity in the ectocervix of women with chronic HIV infection.
    PLoS Pathog. 2024;20:e1012709.
    PubMed     Abstract available
    
    
    October 2024
26. SNOW BJ, Keles NK, Grunst MW, Janaka SK, et al
    Potent broadly neutralizing antibodies mediate efficient antibody-dependent phagocytosis of HIV-infected cells.
    PLoS Pathog. 2024;20:e1012665.
    PubMed     Abstract available
    
    
    
27. JIANG P, Majerciak V, Hu J, Balogh K, et al
    The full transcription map of cottontail rabbit papillomavirus in tumor tissues.
    PLoS Pathog. 2024;20:e1012649.
    PubMed     Abstract available
    
    
    
28. HOWARD JN, Levinger C, Deletsu S, Fromentin R, et al
    Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells.
    PLoS Pathog. 2024;20:e1012601.
    PubMed     Abstract available
    
    
    
29. BRINKKEMPER M, Kerster G, Brouwer PJM, Tran AS, et al
    Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopes.
    PLoS Pathog. 2024;20:e1012558.
    PubMed     Abstract available
    
    
    September 2024
30. DAS MK, Savidge B, Pearl JE, Yates T, et al
    Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis.
    PLoS Pathog. 2024;20:e1012565.
    PubMed     Abstract available
    
    
    
31. HU Z, Cinque P, Dravid A, Hagberg L, et al
    Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection.
    PLoS Pathog. 2024;20:e1012470.
    PubMed     Abstract available
    
    
    
32. CHEN YA, Vickers EN, Aranda-Diaz A, Murphy M, et al
    Genomic epidemiology demonstrates spatially clustered, local transmission of Plasmodium falciparum in forest-going populations in southern Lao PDR.
    PLoS Pathog. 2024;20:e1012194.
    PubMed     Abstract available
    
    
    
33. PETRARA MR, Ruffoni E, Carmona F, Cavallari I, et al
    HIV reservoir and premature aging: risk factors for aging-associated illness in adolescents and young adults with perinatally acquired HIV.
    PLoS Pathog. 2024;20:e1012547.
    PubMed     Abstract available
    
    
    
34. XU X, Niu M, Lamberty BG, Emanuel K, et al
    Microglia and macrophages alterations in the CNS during acute SIV infection: A single-cell analysis in rhesus macaques.
    PLoS Pathog. 2024;20:e1012168.
    PubMed     Abstract available
    
    
    
35. CISNEROS WJ, Soliman SHA, Walter M, Simons LM, et al
    Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal.
    PLoS Pathog. 2024;20:e1012083.
    PubMed     Abstract available
    
    
    
36. DESHPANDE A, Bryer AJ, Andino-Moncada JR, Shi J, et al
    Elasticity of the HIV-1 core facilitates nuclear entry and infection.
    PLoS Pathog. 2024;20:e1012537.
    PubMed     Abstract available
    
    
    
37. ALTMAN PX, Ozorowski G, Stanfield RL, Haakenson J, et al
    Immunization of cows with HIV envelope trimers generates broadly neutralizing antibodies to the V2-apex from the ultralong CDRH3 repertoire.
    PLoS Pathog. 2024;20:e1012042.
    PubMed     Abstract available
    
    
    
38. JENNINGS J, Bracey H, Hong J, Nguyen DT, et al
    The HIV-1 capsid serves as a nanoscale reaction vessel for reverse transcription.
    PLoS Pathog. 2024;20:e1011810.
    PubMed     Abstract available
    
    
    
39. ZHANG Y, Otte F, Stoeckle M, Thielen A, et al
    HIV-1 diversity in viral reservoirs obtained from circulating T-cell subsets during early ART and beyond.
    PLoS Pathog. 2024;20:e1012526.
    PubMed     Abstract available
    
    
    
40. VUKOVICH MJ, Shiakolas AR, Lindenberger J, Richardson RA, et al
    Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral families.
    PLoS Pathog. 2024;20:e1012499.
    PubMed     Abstract available
    
    
    
41. SIMPSON J, Dulek B, Schaughency P, Brenchley JM, et al
    Multi-omics analysis of SIV-specific CD8+ T cells in multiple anatomical sites.
    PLoS Pathog. 2024;20:e1012545.
    PubMed     Abstract available
    
    
    August 2024
42. VARCO-MERTH B, Chaunzwa M, Duell DM, Marenco A, et al
    Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.
    PLoS Pathog. 2024;20:e1012496.
    PubMed     Abstract available
    
    
    
43. ZHOU Z, Guo J, Hetrick B, Tiwari S, et al
    Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties.
    PLoS Pathog. 2024;20:e1012448.
    PubMed     Abstract available
    
    
    
44. VAN DER STRATEN K, Guerra D, Kerster G, Claireaux M, et al
    Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses.
    PLoS Pathog. 2024;20:e1012453.
    PubMed     Abstract available
    
    
    
45. NEUNER-JEHLE N, Zeeb M, Thorball CW, Fellay J, et al
    Using viral diversity to identify HIV-1 variants under HLA-dependent selection in a systematic viral genome-wide screen.
    PLoS Pathog. 2024;20:e1012385.
    PubMed     Abstract available
    
    
    
46. JAMAL EDDINE J, Angelovich TA, Zhou J, Byrnes SJ, et al
    HIV transcription persists in the brain of virally suppressed people with HIV.
    PLoS Pathog. 2024;20:e1012446.
    PubMed     Abstract available
    
    
    
47. XU S, Li H, Ai Z, Guo R, et al
    Exploring viral neuropathic pain: Molecular mechanisms and therapeutic implications.
    PLoS Pathog. 2024;20:e1012397.
    PubMed     Abstract available
    
    
    July 2024
48. PHAN T, Conway JM, Pagane N, Kreig J, et al
    Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion.
    PLoS Pathog. 2024;20:e1012236.
    PubMed     Abstract available
    
    
    
49. UMTHONG S, Timilsina U, D'Angelo MR, Salka K, et al
    MARCH2, a T cell specific factor that restricts HIV-1 infection.
    PLoS Pathog. 2024;20:e1012330.
    PubMed     Abstract available
    
    
    
50. MARSHALL VA, Cornejo Castro EM, Goodman CA, Labo N, et al
    Sequencing of Kaposi's Sarcoma Herpesvirus (KSHV) genomes from persons of diverse ethnicities and provenances with KSHV-associated diseases demonstrate multiple infections, novel polymorphisms, and low intra-host variance.
    PLoS Pathog. 2024;20:e1012338.
    PubMed     Abstract available
    
    
    
51. AL-KAABI M, Deshpande P, Firth M, Pavlos R, et al
    Epistatic interaction between ERAP2 and HLA modulates HIV-1 adaptation and disease outcome in an Australian population.
    PLoS Pathog. 2024;20:e1012359.
    PubMed     Abstract available
    
    
    June 2024
52. WARNER VAN DIJK FA, Tong O, O'Neil TR, Bertram KM, et al
    Characterising plasmacytoid and myeloid AXL+ SIGLEC-6+ dendritic cell functions and their interactions with HIV.
    PLoS Pathog. 2024;20:e1012351.
    PubMed     Abstract available
    
    
    
53. BUSSEY-SUTTON CR, Ward A, Fox JA, Turner AW, et al
    The histone methyltransferase SETD2 regulates HIV expression and latency.
    PLoS Pathog. 2024;20:e1012281.
    PubMed     Abstract available
    
    
    May 2024
54. KARSTEN CB, Buettner FFR, Cajic S, Nehlmeier I, et al
    Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity.
    PLoS Pathog. 2024;20:e1012190.
    PubMed     Abstract available
    
    
    
55. AMORIM SACRAMENTO L, Farias Amorim C, G Lombana C, Beiting D, et al
    CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions.
    PLoS Pathog. 2024;20:e1012211.
    PubMed     Abstract available
    
    
    
56. WINDELS EM, Wampande EM, Joloba ML, Boom WH, et al
    HIV co-infection is associated with reduced Mycobacterium tuberculosis transmissibility in sub-Saharan Africa.
    PLoS Pathog. 2024;20:e1011675.
    PubMed     Abstract available
    
    
    
57. WILHELM E, Poirier M, Da Rocha M, Bedard M, et al
    Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression.
    PLoS Pathog. 2024;20:e1011821.
    PubMed     Abstract available
    
    
    
58. MANICKAM C, Upadhyay AA, Woolley G, Kroll KW, et al
    Natural killer-like B cells are a distinct but infrequent innate immune cell subset modulated by SIV infection of rhesus macaques.
    PLoS Pathog. 2024;20:e1012223.
    PubMed     Abstract available
    
    
    April 2024
59. KUZMINA A, Sadhu L, Hasanuzzaman M, Fujinaga K, et al
    Direct and indirect effects of CYTOR lncRNA regulate HIV gene expression.
    PLoS Pathog. 2024;20:e1012172.
    PubMed     Abstract available
    
    
    
60. KEELE BF, Okoye AA, Fennessey CM, Varco-Merth B, et al
    Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir.
    PLoS Pathog. 2024;20:e1012135.
    PubMed     Abstract available
    
    
    
61. WONG RW, Balachandran A, Cheung PK, Cheng R, et al
    Correction: An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.
    PLoS Pathog. 2024;20:e1012155.
    PubMed     Abstract available
    
    
    March 2024
62. LAYISH B, Goli R, Flick H, Huang SW, et al
    Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions.
    PLoS Pathog. 2024;20:e1011830.
    PubMed     Abstract available
    
    
    
63. ZHANG X, Hu Y, Vandenhoudt RE, Yan C, et al
    Computationally inferred cell-type specific epigenome-wide DNA methylation analysis unveils distinct methylation patterns among immune cells for HIV infection in three cohorts.
    PLoS Pathog. 2024;20:e1012063.
    PubMed     Abstract available
    
    
    February 2024
64. JOSEPH SB, Abrahams MR, Moeser M, Tyers L, et al
    The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.
    PLoS Pathog. 2024;20:e1011974.
    PubMed     Abstract available
    
    
    
65. BENNETT SJ, Yalcin D, Privatt SR, Ngalamika O, et al
    Antibody profiling and predictive modeling discriminate between Kaposi sarcoma and asymptomatic KSHV infection.
    PLoS Pathog. 2024;20:e1012023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.